In a press release on November 28th, Novozymes, the world leader in bioinnovation, revealed it has signed a definitive agreement to acquire Natural Industries Inc. based in Houston, USA. Natural Industries Inc. is a bioagricultural player with annual revenues of $5 million.

This acquisition expands Novozymes’ position in key high-value markets for sustainable bioagriculture solutions.

“I am excited to have the people and technologies of Natural Industries Inc. join our growing BioAg business. Natural Industries Inc. expands Novozymes’ position in the important biocontrol segment and improves our capabilities to grow our business in key US markets on high-value crops like fruits and vegetables,” says Thomas Videbæk, Executive Vice President of Novozymes and head of BioBusiness

Natural Industries Inc. and Novozymes have agreed not to disclose the financial terms of the agreement. The acquisition does not impact Novozymes’ financial guidance for 2012.